These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17049388)

  • 21. Recurrent unstable angina after revascularization in a case of dual left anterior descending coronary artery without risk factors: casualness or destiny?
    Rigatelli G; Franco G; Gemelli M; Zamboni A; Visentin M; Bovolon D; Rigatelli G
    Int J Cardiol; 2004 Oct; 97(1):133-4. PubMed ID: 15336820
    [No Abstract]   [Full Text] [Related]  

  • 22. An isolated right ventricular myocardial infarction and severe tricuspid regurgitation due to occlusion of a non-dominant right coronary artery: role of delayed revascularization.
    Vural M; Uslu A; Bülbül S
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):376-7. PubMed ID: 20693136
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplasty.
    Vignali L; Talanas G; Menozzi A; Cattabiani MA; Solinas E; Aurier E; Ardissino D
    Minerva Cardioangiol; 2008 Feb; 56(1):1-11. PubMed ID: 18432163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents.
    Hannan EL; Racz M; Holmes DR; Sharma S; Katz S; Walford G; King SB; Clark LT; Jones RH
    Am Heart J; 2007 Sep; 154(3):545-53. PubMed ID: 17719304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.
    Valgimigli M; Malagutti P; Rodriguez Granillo GA; Tsuchida K; Garcia-Garcia HM; van Mieghem CA; Van der Giessen WJ; De Feyter P; de Jaegere P; Van Domburg RT; Serruys PW
    Am Heart J; 2006 Nov; 152(5):896-902. PubMed ID: 17070153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery.
    Jaffery Z; Kowalski M; Weaver WD; Khanal S
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):691-7. PubMed ID: 17300948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
    Aoki J; Kirtane AJ; Dangas GD; Lansky AJ; Morales A; Kimura M; Kim YH; Moussa I; Weisz G; Kreps EM; Collins M; Frankin-Bond T; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2008 Jan; 101(1):58-62. PubMed ID: 18157966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET).
    Brunner-La Rocca HP; Kaiser C; Pfisterer M;
    Eur Heart J; 2007 Mar; 28(6):719-25. PubMed ID: 17298975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions.
    Ge L; Cosgrave J; Iakovou I; Qian JY; Agostoni P; Sangiorgi GM; Airoldi F; Michev I; Chieffo A; Corvaja N; Colombo A; Ge JB
    Chin Med J (Engl); 2007 Apr; 120(7):545-51. PubMed ID: 17442200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery.
    Ben-Gal Y; Mohr R; Braunstein R; Finkelstein A; Hansson N; Hendler A; Moshkovitz Y; Uretzky G
    Ann Thorac Surg; 2006 Dec; 82(6):2067-71. PubMed ID: 17126111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2008; 14(1):131-41. PubMed ID: 19156043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe myocardial ischemia due to a large vascular malformation of the left anterior descending coronary artery with a fistulous connection from the right coronary artery.
    Ibebuogu UN; Kapoor D; Robinson VJ
    J Invasive Cardiol; 2009 Jan; 21(1):E1-2. PubMed ID: 19126926
    [No Abstract]   [Full Text] [Related]  

  • 36. Short and long-term outcomes of two drug eluting stents in bifurcation lesions.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; Wu Y; Dai J
    Chin Med J (Engl); 2007 Feb; 120(3):183-6. PubMed ID: 17355818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcomes following coronary stenting.
    Anstrom KJ; Kong DF; Shaw LK; Califf RM; Kramer JM; Peterson ED; Rao SV; Matchar DB; Mark DB; Harrington RA; Eisenstein EL
    Arch Intern Med; 2008 Aug; 168(15):1647-55. PubMed ID: 18695078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.